| Primary |
| Glomerulonephritis |
14.6% |
| Chronic Obstructive Pulmonary Disease |
10.4% |
| Immune Thrombocytopenic Purpura |
10.4% |
| Lymphocytic Leukaemia |
8.3% |
| Colitis Ulcerative |
4.2% |
| Constipation |
4.2% |
| Gastritis Prophylaxis |
4.2% |
| Hypercholesterolaemia |
4.2% |
| Hypertension |
4.2% |
| Laryngitis |
4.2% |
| Nephrotic Syndrome |
4.2% |
| Osteoporosis Prophylaxis |
4.2% |
| Prophylaxis Of Neural Tube Defect |
4.2% |
| Rheumatoid Arthritis |
4.2% |
| Sinusitis |
4.2% |
| Ankylosing Spondylitis |
2.1% |
| Arthritis |
2.1% |
| Cardiac Failure |
2.1% |
| Diplopia |
2.1% |
| Ear Disorder |
2.1% |
|
| Talipes |
13.3% |
| Exposure During Pregnancy |
6.7% |
| Muscular Weakness |
6.7% |
| Myocardial Infarction |
6.7% |
| Osteoporotic Fracture |
6.7% |
| Polyneuropathy |
6.7% |
| Premature Rupture Of Membranes |
6.7% |
| Spinal Compression Fracture |
6.7% |
| Subdural Haematoma |
6.7% |
| Tendon Rupture |
6.7% |
| Thirst |
6.7% |
| Visual Acuity Reduced |
6.7% |
| Visual Impairment |
6.7% |
| Weight Increased |
6.7% |
|
| Secondary |
| Hypertension |
26.9% |
| Rheumatoid Arthritis |
21.7% |
| Arthralgia |
8.7% |
| Product Used For Unknown Indication |
7.3% |
| Renal Transplant |
3.5% |
| Pneumonia |
3.4% |
| B-cell Lymphoma |
2.9% |
| Immune Thrombocytopenic Purpura |
2.7% |
| Diffuse Large B-cell Lymphoma |
2.6% |
| Plasma Cell Myeloma |
2.6% |
| Osteoarthritis |
2.5% |
| Prophylaxis |
2.5% |
| Drug Use For Unknown Indication |
2.4% |
| Glomerulonephritis |
2.3% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Prophylaxis Against Transplant Rejection |
1.4% |
| Malignant Lymphoid Neoplasm |
1.3% |
| Klebsiella Infection |
1.2% |
| Granulomatosis With Polyangiitis |
1.2% |
| Hypercholesterolaemia |
1.2% |
|
| Thrombophlebitis Septic |
18.2% |
| Talipes |
9.1% |
| Type 1 Diabetes Mellitus |
6.5% |
| Vomiting |
6.5% |
| Pyrexia |
5.2% |
| Stomatitis |
5.2% |
| Upper Gastrointestinal Haemorrhage |
5.2% |
| Clostridium Difficile Colitis |
3.9% |
| Gastric Ulcer |
3.9% |
| Myocardial Infarction |
3.9% |
| Renal Failure |
3.9% |
| Sepsis |
3.9% |
| Staphylococcal Sepsis |
3.9% |
| Thirst |
3.9% |
| Urinary Tract Infection |
3.9% |
| Lymphoma |
2.6% |
| Malnutrition |
2.6% |
| Muscular Weakness |
2.6% |
| Progressive Multifocal Leukoencephalopathy |
2.6% |
| Respiratory Failure |
2.6% |
|
| Concomitant |
| Rheumatoid Arthritis |
30.5% |
| Product Used For Unknown Indication |
23.5% |
| Hypertension |
10.0% |
| Drug Use For Unknown Indication |
6.5% |
| Prophylaxis |
4.2% |
| Pain |
4.1% |
| Osteoporosis |
3.9% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Premedication |
2.2% |
| Crohn's Disease |
1.7% |
| Ankylosing Spondylitis |
1.3% |
| Immunosuppression |
1.3% |
| Renal Transplant |
1.2% |
| Asthma |
1.2% |
| Diabetes Mellitus |
1.1% |
| Infection Prophylaxis |
1.1% |
| Systemic Lupus Erythematosus |
1.1% |
| Sleep Disorder |
1.0% |
| B-cell Lymphoma |
0.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.9% |
|
| Pyrexia |
10.1% |
| Vomiting |
9.0% |
| Pneumonia |
7.1% |
| Urinary Tract Infection |
6.3% |
| Renal Failure |
6.1% |
| Sepsis |
5.8% |
| Weight Decreased |
5.6% |
| Urticaria |
5.3% |
| Rheumatoid Arthritis |
4.5% |
| Transaminases Increased |
4.5% |
| Syncope |
4.2% |
| Systemic Lupus Erythematosus |
4.2% |
| Thrombocytopenia |
4.2% |
| Diabetes Mellitus |
3.7% |
| Pulmonary Embolism |
3.7% |
| Headache |
3.2% |
| Nausea |
3.2% |
| Pancytopenia |
3.2% |
| Tuberculosis |
3.2% |
| Dermatitis Psoriasiform |
2.9% |
|
| Interacting |
| Hypertension |
20.5% |
| Spondyloarthropathy |
13.6% |
| Pneumonia |
9.1% |
| Chronic Obstructive Pulmonary Disease |
6.8% |
| Muscular Weakness |
6.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.8% |
| Colitis Ulcerative |
4.5% |
| Crohn's Disease |
4.5% |
| Benign Prostatic Hyperplasia |
2.3% |
| Coronary Artery Disease |
2.3% |
| Dementia |
2.3% |
| Diabetes Mellitus |
2.3% |
| Flatulence |
2.3% |
| Hyperlipidaemia |
2.3% |
| Hyperthyroidism |
2.3% |
| Ischaemic Heart Disease Prophylaxis |
2.3% |
| Pain |
2.3% |
| Tooth Infection |
2.3% |
| Type 1 Diabetes Mellitus |
2.3% |
| Type 2 Diabetes Mellitus |
2.3% |
|
| Drug Interaction |
42.9% |
| Metrorrhagia |
42.9% |
| Pancytopenia |
14.3% |
|
